| Dr Thomas Glenn Lewis, MD | |
|
4439 State Route 159 Ste G50, Chillicothe, OH 45601-7202 | |
| (740) 779-8580 | |
| Not Available |
| Full Name | Dr Thomas Glenn Lewis |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 21 Years |
| Location | 4439 State Route 159 Ste G50, Chillicothe, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043429640 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 43010081467 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adena Regional Medical Center | Chillicothe, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Adena Medical Group Llc | 1153456579 | 342 |
News Archive
Proteonomix, Inc., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, today announced that it has entered into an exclusive worldwide license agreement for a novel source of primary human cells that secrete a factor capable of inhibiting tumor cell growth and causing tumor cell death.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics, presented Phase 2 efficacy results for NeuVax in combination with trastuzumab at the American Society of Clinical Oncology (ASCO) annual meeting.
Oxford University Press (OUP) is pleased to announce that it has entered a new long-term collaboration with the Medical Council on Alcohol (MCA) to jointly publish the journal Alcohol and Alcoholism.
More than four hundred foster-care students within the Twin Rivers Unified School District will be able to receive free dental care thanks to a new telemedicine project created jointly by the California Dental Association Foundation, University of the Pacific Arthur A. Dugoni School of Dentistry and the California HealthCare Foundation with start-up funding from Verizon.
› Verified 5 days ago
| Entity Name | Adena Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235468083 PECOS PAC ID: 1153456579 Enrollment ID: O20100323001007 |
News Archive
Proteonomix, Inc., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, today announced that it has entered into an exclusive worldwide license agreement for a novel source of primary human cells that secrete a factor capable of inhibiting tumor cell growth and causing tumor cell death.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics, presented Phase 2 efficacy results for NeuVax in combination with trastuzumab at the American Society of Clinical Oncology (ASCO) annual meeting.
Oxford University Press (OUP) is pleased to announce that it has entered a new long-term collaboration with the Medical Council on Alcohol (MCA) to jointly publish the journal Alcohol and Alcoholism.
More than four hundred foster-care students within the Twin Rivers Unified School District will be able to receive free dental care thanks to a new telemedicine project created jointly by the California Dental Association Foundation, University of the Pacific Arthur A. Dugoni School of Dentistry and the California HealthCare Foundation with start-up funding from Verizon.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Glenn Lewis, MD 4439 State Route 159 Ste G50, Chillicothe, OH 45601-7202 Ph: (740) 779-8580 | Dr Thomas Glenn Lewis, MD 4439 State Route 159 Ste G50, Chillicothe, OH 45601-7202 Ph: (740) 779-8580 |
News Archive
Proteonomix, Inc., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, today announced that it has entered into an exclusive worldwide license agreement for a novel source of primary human cells that secrete a factor capable of inhibiting tumor cell growth and causing tumor cell death.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics, presented Phase 2 efficacy results for NeuVax in combination with trastuzumab at the American Society of Clinical Oncology (ASCO) annual meeting.
Oxford University Press (OUP) is pleased to announce that it has entered a new long-term collaboration with the Medical Council on Alcohol (MCA) to jointly publish the journal Alcohol and Alcoholism.
More than four hundred foster-care students within the Twin Rivers Unified School District will be able to receive free dental care thanks to a new telemedicine project created jointly by the California Dental Association Foundation, University of the Pacific Arthur A. Dugoni School of Dentistry and the California HealthCare Foundation with start-up funding from Verizon.
› Verified 5 days ago
Dr. Lindsey Dohse, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4439 State Route 159, Suite G50, Chillicothe, OH 45601 Phone: 570-779-8580 | |
Kelly Ann Gallina, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4439 State Route 159, Suite G50, Chillicothe, OH 45601 Phone: 740-779-8580 Fax: 740-779-8589 | |
Nitin Tiwari, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4439 State Route 159 Ste G50, Chillicothe, OH 45601 Phone: 740-779-8580 Fax: 740-779-8589 | |
Dr. Chase W Kwon, MD Dermatology Medicare: Medicare Enrolled Practice Location: 272 Hospital Rd Ste G15, Chillicothe, OH 45601 Phone: 740-779-8580 |